Loading...

GEN-06 CLINICAL COURSE AFTER TUMOR RECURRENCE OF MGMT HYPERMETHYLATED GLIOBLASTOMA

MGMT methylation in glioblastoma is a biomarker for determining treatment responsiveness and predicting prognosis. We analyzed whether there were differences in the prognosis between glioblastoma with MGMT hypermethylation and other glioblastomas after tumor recurrence. We enrolled 184 patients who...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neurooncol Adv
Main Authors: Adachi, Junichi, Shirahata, Mitsuaki, Suzuki, Tomonari, Mishima, Kazuhiko, Fujimaki, Takamitsu, Nishikawa, Ryo
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213324/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.035
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!